KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Shares Outstanding (Diluted Average) (2019 - 2025)

Historic Shares Outstanding (Diluted Average) for Ginkgo Bioworks Holdings (DNA) over the last 7 years, with Q3 2025 value amounting to $55.6 million.

  • Ginkgo Bioworks Holdings' Shares Outstanding (Diluted Average) rose 648.39% to $55.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.6 million, marking a year-over-year increase of 648.39%. This contributed to the annual value of $51.9 million for FY2024, which is 675.6% up from last year.
  • Ginkgo Bioworks Holdings' Shares Outstanding (Diluted Average) amounted to $55.6 million in Q3 2025, which was up 648.39% from $54.9 million recorded in Q2 2025.
  • In the past 5 years, Ginkgo Bioworks Holdings' Shares Outstanding (Diluted Average) registered a high of $1.9 billion during Q2 2023, and its lowest value of $1.6 million during Q1 2022.
  • For the 5-year period, Ginkgo Bioworks Holdings' Shares Outstanding (Diluted Average) averaged around $643.9 million, with its median value being $54.6 million (2025).
  • Per our database at Business Quant, Ginkgo Bioworks Holdings' Shares Outstanding (Diluted Average) surged by 11913091.76% in 2023 and then plummeted by 9738.43% in 2024.
  • Quarter analysis of 5 years shows Ginkgo Bioworks Holdings' Shares Outstanding (Diluted Average) stood at $1.4 billion in 2021, then plummeted by 96.91% to $42.0 million in 2022, then increased by 15.75% to $48.6 million in 2023, then rose by 6.76% to $51.9 million in 2024, then grew by 7.21% to $55.6 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $55.6 million in Q3 2025, compared to $54.9 million in Q2 2025 and $54.2 million in Q1 2025.